Please login to the form below

Not currently logged in
Email:
Password:

Heptares Pharma

This page shows the latest Heptares Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva buys into Heptares oral CGRP programme for migraine

Teva buys into Heptares oral CGRP programme for migraine

Teva buys into Heptares oral CGRP programme for migraine. Signs$410m alliance for early-stage candidates in potentially-lucrative drug class. ... Teva will co-develop Heptares Pharma's portfolio of migraine therapies in a new alliance valued at up to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Former Amgen EVP Roger Perlmutter joins Heptares board Former Amgen EVP Roger Perlmutter joins Heptares board

    UK-based Heptares, which focuses on researching medicines that target G protein-coupled receptors across a range of conditions, has made several deals recently with large pharma companies, including AstraZeneca and ... We are delighted to welcome Roger

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics